1. Home
  2. TPCS vs CALC Comparison

TPCS vs CALC Comparison

Compare TPCS & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPCS
  • CALC
  • Stock Information
  • Founded
  • TPCS 1956
  • CALC 2011
  • Country
  • TPCS United States
  • CALC United States
  • Employees
  • TPCS N/A
  • CALC N/A
  • Industry
  • TPCS Metal Fabrications
  • CALC Biotechnology: Pharmaceutical Preparations
  • Sector
  • TPCS Industrials
  • CALC Health Care
  • Exchange
  • TPCS Nasdaq
  • CALC Nasdaq
  • Market Cap
  • TPCS 31.5M
  • CALC 36.0M
  • IPO Year
  • TPCS N/A
  • CALC N/A
  • Fundamental
  • Price
  • TPCS $3.19
  • CALC $2.61
  • Analyst Decision
  • TPCS
  • CALC Strong Buy
  • Analyst Count
  • TPCS 0
  • CALC 5
  • Target Price
  • TPCS N/A
  • CALC $18.20
  • AVG Volume (30 Days)
  • TPCS 22.5K
  • CALC 31.0K
  • Earning Date
  • TPCS 01-21-2025
  • CALC 03-27-2025
  • Dividend Yield
  • TPCS N/A
  • CALC N/A
  • EPS Growth
  • TPCS N/A
  • CALC N/A
  • EPS
  • TPCS N/A
  • CALC N/A
  • Revenue
  • TPCS $33,182,059.00
  • CALC N/A
  • Revenue This Year
  • TPCS N/A
  • CALC N/A
  • Revenue Next Year
  • TPCS N/A
  • CALC N/A
  • P/E Ratio
  • TPCS N/A
  • CALC N/A
  • Revenue Growth
  • TPCS 6.44
  • CALC N/A
  • 52 Week Low
  • TPCS $2.85
  • CALC $2.05
  • 52 Week High
  • TPCS $5.95
  • CALC $6.27
  • Technical
  • Relative Strength Index (RSI)
  • TPCS 43.57
  • CALC 43.94
  • Support Level
  • TPCS $3.09
  • CALC $2.32
  • Resistance Level
  • TPCS $3.25
  • CALC $3.05
  • Average True Range (ATR)
  • TPCS 0.13
  • CALC 0.27
  • MACD
  • TPCS 0.01
  • CALC -0.01
  • Stochastic Oscillator
  • TPCS 26.67
  • CALC 43.29

About TPCS TechPrecision Corporation Common stock

Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components.

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.

Share on Social Networks: